Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Meghanath Yenni: Anticoagulant Reversal in Clinical Practice
Meghanath Yenni/LinkedIn
Aug 4, 2026, 17:03

Meghanath Yenni: Anticoagulant Reversal in Clinical Practice

Meghanath Yenni, Consultant Physician at Medicover Hospitals, shared a post on LinkedIn:

”Anticoagulant Reversal in Clinical Practice:

As anticoagulant use continues to increase, clinicians are encountering more patients with major bleeding, intracranial hemorrhage, and urgent procedures requiring rapid reversal.

A recent 2026 New England Journal of Medicine review provides a practical, evidence-based update on the currently available antidotes and how they should be used.

  • Reserve reversal agents for life-threatening or uncontrolled bleeding, or when emergency surgery cannot be delayed.
  • Warfarin: Rapid reversal requires IV vitamin K plus 4-factor prothrombin complex concentrate (4F-PCC).
  • Unfractionated heparin: Protamine remains the antidote of choice. It partially reverses LMWH and has no effect on fondaparinux.
  • Dabigatran: Idarucizumab provides rapid, specific reversal, although delayed dabigatran rebound may occur in some patients.
  • Factor Xa inhibitors (apixaban/rivaroxaban): Andexanet alfa provides targeted reversal in carefully selected patients but should be used judiciously because of thrombotic risk, cost, and limited indications. 4F-PCC remains the most widely used nonspecific alternative when andexanet is unavailable or unsuitable.

Before administering any antidote, ask four essential questions:

  1. Is the bleeding truly life-threatening?
  2. Is clinically significant anticoagulant still present?
  3. Can the procedure safely be delayed?
  4. Does the patient’s thrombotic risk outweigh the benefit of reversal?

As newer anticoagulants become increasingly common, understanding when—and when not—to reverse anticoagulation is becoming just as important as knowing which antidote to use.”

Meghanath Yenni: Anticoagulant Reversal in Clinical Practice

Stay updated with Hemostasis Today.

Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine Meghanath Yenni
NewsFeed